×
About 141,932 results

ALLMedicine™ Schizophrenia Center

Research & Reviews  67,165 results

Escape and absconding among offenders with schizophrenia spectrum disorder - an explora...
https://doi.org/10.1186/s12888-021-03117-1 10.1002/cbm.1982 10.1371/journal.pone.0138819 10.1177/070674377401900504 10.1520/JFS10963J 10.1192/pb.22.6.351 10.1046/j.1365-2850.1998.00149.x 10.1046/j.1351-0126.2001.00426.x 10.1192/bjp.156.4.488 10.1016/S0010-440X(62)80037-6 10.1080/j.1440-1614.1999.00603.x 10.1080/00332747.1966.11023451 10.1016/S2215-0366(16)30168-7 10.1111/j.1447-0349.2012.00873.x 10.1080/09585189308407791 10.1080/09585189908402138 10.1080/09585189008408474 10.1080/09585189408412298 10.1080/09585189508409895 10.1186/1471-244X-14-91 10.1080/14789949.2018.1467948 10.1186/s12888-015-0474-1 10.1046/j.1365-2850.1999.630213.x 10.1046/j.1365-2648.2000.01523.x 10.1046/j.1365-2850.1999.630199.x 10.1046/j.1365-2850.2003.00619.x 10.1017/S0790966700002275 10.1177/088626097012006002 10.1111/j.1447-0349.2009.00660.x 10.1111/inm.12100 10.1080/016128400247988 10.1111/j.1447-0349.2008.00562.x 10.1192/bjp.154.3.368 10.1111/j.1365-2702.2010.03553.x 10.1177/002076409904500204 10.1111/j.1365-2850.2011.01716.x 10.1080/09585180050142570 10.1016/j.pmrj.2009.10.004 10.1136/bmj.316.7139.1236 10.1146/annurev-clinpsy-032816-045037 10.1016/j.cobeha.2017.07.003 10.1080/14789940802542808 10.1007/978-1-4614-7138-7 10.1002/sim.4780130513 10.1017/S0033291716003494 10.1006/jmps.1999.1279 10.1016/j.ins.2012.10.039 10.1093/schbul/sbv037 10.1093/schbul/sbu001 10.1176/appi.focus.12.2.235 10.1016/j.avb.2014.04.014 10.1016/j.schres.2012.06.041 10.1016/j.eurpsy.2019.05.005 10.1177/0004867415587745 10.1093/oxfordjournals.schbul.a006867 10.1002/cbm.1910 10.1371/journal.pone.0055942 10.1001/archgenpsychiatry.2008.537 10.1176/appi.ajp.161.4.716 10.1176/appi.ajp.157.4.566 10.1037/a0016311 10.2307/2096235 10.1007/s00127-005-0020-4 10.1001/archpsyc.55.5.393 10.1001/archpsyc.63.5.490 10.1007/s10979-007-9095-7 10.1192/bjp.147.5.491 10.1371/journal.pone.0067863 10.1109/TKDE.2008.239
BMC Psychiatry; Kirchebner J, Lau S et. al.

Mar 5th, 2021 - Escape and absconding, especially in forensic settings, can have serious consequences for patients, staff and institutions. Several characteristics of affected patients could be identified so far, albeit based on heterogeneous patient populations,...

Successful Introduction of Paliperidone Palmitate for Pregnant Woman With Schizophrenia...
https://doi.org/10.1097/JCP.0000000000001338 10.1007/s00737-018-0828-z 10.1016/j.semperi.2020.151230
Journal of Clinical Psychopharmacology; Iwata Y, Aruga Y et. al.

Mar 5th, 2021 - Successful Introduction of Paliperidone Palmitate for Pregnant Woman With Schizophrenia: Case Presentation and Literature Review.|2021|Iwata Y,Aruga Y,Ohtsuki M,Inoue M,Yasuda K,|

Comment on Starke et al.: "Computing schizophrenia: ethical challenges for machine lear...
https://doi.org/10.1017/S0033291721000684
Psychological Medicine; Gauld C, Micoulaud-Franchi JA et. al.

Mar 4th, 2021 - Comment on Starke et al.: "Computing schizophrenia: ethical challenges for machine learning in psychiatry": From machine learning to student learning: pedagogical challenges for psychiatry - Corrigendum.|2021|Gauld C,Micoulaud-Franchi JA,Dumas G,|

Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutation.
https://doi.org/10.1038/s41467-021-21713-3 10.1176/appi.ajp.2020.20101481 10.1016/j.biopsych.2014.07.011 10.1038/mp.2012.20 10.1038/nrm3448 10.1038/mp.2017.40 10.1146/annurev-neuro-062012-170328 10.1016/j.conb.2015.11.003 10.1038/mp.2011.13 10.1038/nature09915 10.1038/mp.2013.67 10.1016/j.stem.2014.05.003 10.1016/j.scr.2018.05.013 10.1038/s41398-018-0228-1 10.1038/nature13716 10.1016/j.stemcr.2014.01.009 10.1038/sj.mp.4001667 10.1016/S0896-6273(00)81015-6 10.1523/JNEUROSCI.5317-07.2008 10.1113/jphysiol.2010.200477 10.1126/science.1112915 10.1073/pnas.0813020106 10.1517/13543784.11.1.1 10.1038/nn.4161 10.1016/0304-3940(87)90584-2 10.1192/bjp.168.5.562 10.1001/archpsyc.1992.01820120063009 10.1176/jnp.6.4.348 10.1016/S0006-3223(02)01641-4 10.1007/s002130000590 10.2174/1381612819666131216114240 10.1016/j.pnpbp.2003.09.003 10.1016/j.neuron.2006.09.023 10.1038/nm1056 10.1371/journal.pone.0025735 10.1038/mp.2013.38 10.1016/j.neures.2011.05.014 10.1016/j.biopsych.2009.09.017 10.1073/pnas.0908706106 10.1016/j.neuron.2007.04.015 10.1073/pnas.0704774104 10.1073/pnas.0706900104 10.1038/sj.mp.4002079 10.1093/hmg/ddr400
Nature Communications; Kim NS, Wen Z et. al.

Mar 4th, 2021 - We previously identified a causal link between a rare patient mutation in DISC1 (disrupted-in-schizophrenia 1) and synaptic deficits in cortical neurons differentiated from isogenic patient-derived induced pluripotent stem cells (iPSCs). Here we f...

Structural insights into the inhibition of glycine reuptake.
https://doi.org/10.1038/s41586-021-03274-z 10.1038/nrd3893 10.1038/328215a0 10.1038/325529a0 10.1080/13543776.2018.1429408 10.1124/pr.108.000869 10.1016/S0896-6273(03)00672-X 10.1093/cercor/bhh147 10.1111/j.1471-4159.2005.03438.x 10.1016/j.brainresbull.2010.04.006 10.2533/chimia.2018.477 10.1007/s00406-007-0757-8 10.1021/jm100210p 10.1016/j.drudis.2009.05.002 10.1016/j.biopsych.2017.12.019 10.1038/211969a0 10.1038/nsmb.2816 10.1038/nsmb.2894 10.1038/nature12533 10.1038/s41586-019-1135-1 10.1038/s41467-020-14735-w 10.1038/nature06038 10.1038/nature17629 10.1038/ncomms11673 10.1016/j.neuropharm.2011.11.008 10.1016/j.bmcl.2010.09.124 10.1016/S0960-894X(01)00355-9 10.7554/eLife.34317 10.1016/j.sbi.2009.06.002 10.1073/pnas.1903020116 10.1021/acschemneuro.7b00407 10.1016/j.cell.2019.07.028 10.1074/jbc.M609158200 10.1097/ALN.0b013e31823cf233 10.1074/jbc.M704456200 10.1016/j.biopsych.2016.11.014 10.1038/npp.2012.212 10.1016/j.celrep.2017.12.019 10.1074/jbc.270.16.9437 10.1107/S2052252513033939 10.1107/S1399004715017927 10.1107/S0907444909047337 10.1107/S0907444910007493 10.1107/S2059798318002425 10.1107/S2059798319011471 10.1016/j.str.2012.06.009 10.1016/j.str.2008.02.004 10.1021/jm0603365 10.1006/jmbi.1996.0897 10.1093/nar/gkn197 10.1021/jm0011272 10.1093/nar/gkz268 10.1093/nar/gkw408 10.1107/S0907444910045749 10.1073/pnas.1221279110 10.1126/science.1166777 10.1038/nsb0497-269 10.1126/science.1218231
Nature Shahsavar A, Stohler P et. al.

Mar 4th, 2021 - The human glycine transporter 1 (GlyT1) regulates glycine-mediated neuronal excitation and inhibition through the sodium- and chloride-dependent reuptake of glycine1-3. Inhibition of GlyT1 prolongs neurotransmitter signalling, and has long been a ...

see more →

Guidelines  45 results

The American Psychiatric Association Practice Guideline for the Treatment of Patients W...
https://doi.org/10.1176/appi.ajp.2020.177901
The American Journal of Psychiatry; Keepers GA, Fochtmann LJ et. al.

Sep 1st, 2020 - The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia.|2020|Keepers GA,Fochtmann LJ,Anzia JM,Benjamin S,Lyness JM,|methods,methods,methods,classification,therapeutic use,diagnosis,therapy,

CAPLYTA® (lumateperone) | Now Approved | caplyta.com‎
https://www.caplyta.com/‎

Jan 13th, 2020 - Learn about a new treatment. See full safety information, PI, and boxed warning. Get information about this orally administered capsule. Press Release. Prescribing Information. MOA. Important Safety Info. Dosing & Administration.

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated r...
https://doi.org/10.1177/0269881119889296
Journal of Psychopharmacology (Oxford, England); Barnes TR, Drake R et. al.

Dec 12th, 2019 - These updated guidelines from the British Association for Psychopharmacology replace the original version published in 2011. They address the scope and targets of pharmacological treatment for schizophrenia. A consensus meeting was held in 2017, i...

Cannabidiol as a potential treatment for psychosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843725/
Therapeutic Advances in Psychopharmacology; Davies C,et al

Nov 7th, 2019 - Psychotic disorders such as schizophrenia are heterogeneous and often debilitating conditions that contribute substantially to the global burden of disease. The introduction of dopamine D2 receptor antagonists in the 1950s revolutionised the treat...

U.S. FDA Approves SECUADO® (asenapine) Transdermal System, the First-and-Only Transdermal Patch for the Treatment of Adults with Schizophrenia
http://www.noven.com/PR101519.php

Oct 14th, 2019 - Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S. Food and Drug Administration (FDA) has approved SECUADO® (asenapine) transdermal system, the first-and-only transdermal patch fo...

see more →

Drugs  1,639 results see all →

Clinicaltrials.gov  70,387 results

Escape and absconding among offenders with schizophrenia spectrum disorder - an explora...
https://doi.org/10.1186/s12888-021-03117-1 10.1002/cbm.1982 10.1371/journal.pone.0138819 10.1177/070674377401900504 10.1520/JFS10963J 10.1192/pb.22.6.351 10.1046/j.1365-2850.1998.00149.x 10.1046/j.1351-0126.2001.00426.x 10.1192/bjp.156.4.488 10.1016/S0010-440X(62)80037-6 10.1080/j.1440-1614.1999.00603.x 10.1080/00332747.1966.11023451 10.1016/S2215-0366(16)30168-7 10.1111/j.1447-0349.2012.00873.x 10.1080/09585189308407791 10.1080/09585189908402138 10.1080/09585189008408474 10.1080/09585189408412298 10.1080/09585189508409895 10.1186/1471-244X-14-91 10.1080/14789949.2018.1467948 10.1186/s12888-015-0474-1 10.1046/j.1365-2850.1999.630213.x 10.1046/j.1365-2648.2000.01523.x 10.1046/j.1365-2850.1999.630199.x 10.1046/j.1365-2850.2003.00619.x 10.1017/S0790966700002275 10.1177/088626097012006002 10.1111/j.1447-0349.2009.00660.x 10.1111/inm.12100 10.1080/016128400247988 10.1111/j.1447-0349.2008.00562.x 10.1192/bjp.154.3.368 10.1111/j.1365-2702.2010.03553.x 10.1177/002076409904500204 10.1111/j.1365-2850.2011.01716.x 10.1080/09585180050142570 10.1016/j.pmrj.2009.10.004 10.1136/bmj.316.7139.1236 10.1146/annurev-clinpsy-032816-045037 10.1016/j.cobeha.2017.07.003 10.1080/14789940802542808 10.1007/978-1-4614-7138-7 10.1002/sim.4780130513 10.1017/S0033291716003494 10.1006/jmps.1999.1279 10.1016/j.ins.2012.10.039 10.1093/schbul/sbv037 10.1093/schbul/sbu001 10.1176/appi.focus.12.2.235 10.1016/j.avb.2014.04.014 10.1016/j.schres.2012.06.041 10.1016/j.eurpsy.2019.05.005 10.1177/0004867415587745 10.1093/oxfordjournals.schbul.a006867 10.1002/cbm.1910 10.1371/journal.pone.0055942 10.1001/archgenpsychiatry.2008.537 10.1176/appi.ajp.161.4.716 10.1176/appi.ajp.157.4.566 10.1037/a0016311 10.2307/2096235 10.1007/s00127-005-0020-4 10.1001/archpsyc.55.5.393 10.1001/archpsyc.63.5.490 10.1007/s10979-007-9095-7 10.1192/bjp.147.5.491 10.1371/journal.pone.0067863 10.1109/TKDE.2008.239
BMC Psychiatry; Kirchebner J, Lau S et. al.

Mar 5th, 2021 - Escape and absconding, especially in forensic settings, can have serious consequences for patients, staff and institutions. Several characteristics of affected patients could be identified so far, albeit based on heterogeneous patient populations,...

Successful Introduction of Paliperidone Palmitate for Pregnant Woman With Schizophrenia...
https://doi.org/10.1097/JCP.0000000000001338 10.1007/s00737-018-0828-z 10.1016/j.semperi.2020.151230
Journal of Clinical Psychopharmacology; Iwata Y, Aruga Y et. al.

Mar 5th, 2021 - Successful Introduction of Paliperidone Palmitate for Pregnant Woman With Schizophrenia: Case Presentation and Literature Review.|2021|Iwata Y,Aruga Y,Ohtsuki M,Inoue M,Yasuda K,|

Comment on Starke et al.: "Computing schizophrenia: ethical challenges for machine lear...
https://doi.org/10.1017/S0033291721000684
Psychological Medicine; Gauld C, Micoulaud-Franchi JA et. al.

Mar 4th, 2021 - Comment on Starke et al.: "Computing schizophrenia: ethical challenges for machine learning in psychiatry": From machine learning to student learning: pedagogical challenges for psychiatry - Corrigendum.|2021|Gauld C,Micoulaud-Franchi JA,Dumas G,|

Pharmacological rescue in patient iPSC and mouse models with a rare DISC1 mutation.
https://doi.org/10.1038/s41467-021-21713-3 10.1176/appi.ajp.2020.20101481 10.1016/j.biopsych.2014.07.011 10.1038/mp.2012.20 10.1038/nrm3448 10.1038/mp.2017.40 10.1146/annurev-neuro-062012-170328 10.1016/j.conb.2015.11.003 10.1038/mp.2011.13 10.1038/nature09915 10.1038/mp.2013.67 10.1016/j.stem.2014.05.003 10.1016/j.scr.2018.05.013 10.1038/s41398-018-0228-1 10.1038/nature13716 10.1016/j.stemcr.2014.01.009 10.1038/sj.mp.4001667 10.1016/S0896-6273(00)81015-6 10.1523/JNEUROSCI.5317-07.2008 10.1113/jphysiol.2010.200477 10.1126/science.1112915 10.1073/pnas.0813020106 10.1517/13543784.11.1.1 10.1038/nn.4161 10.1016/0304-3940(87)90584-2 10.1192/bjp.168.5.562 10.1001/archpsyc.1992.01820120063009 10.1176/jnp.6.4.348 10.1016/S0006-3223(02)01641-4 10.1007/s002130000590 10.2174/1381612819666131216114240 10.1016/j.pnpbp.2003.09.003 10.1016/j.neuron.2006.09.023 10.1038/nm1056 10.1371/journal.pone.0025735 10.1038/mp.2013.38 10.1016/j.neures.2011.05.014 10.1016/j.biopsych.2009.09.017 10.1073/pnas.0908706106 10.1016/j.neuron.2007.04.015 10.1073/pnas.0704774104 10.1073/pnas.0706900104 10.1038/sj.mp.4002079 10.1093/hmg/ddr400
Nature Communications; Kim NS, Wen Z et. al.

Mar 4th, 2021 - We previously identified a causal link between a rare patient mutation in DISC1 (disrupted-in-schizophrenia 1) and synaptic deficits in cortical neurons differentiated from isogenic patient-derived induced pluripotent stem cells (iPSCs). Here we f...

Structural insights into the inhibition of glycine reuptake.
https://doi.org/10.1038/s41586-021-03274-z 10.1038/nrd3893 10.1038/328215a0 10.1038/325529a0 10.1080/13543776.2018.1429408 10.1124/pr.108.000869 10.1016/S0896-6273(03)00672-X 10.1093/cercor/bhh147 10.1111/j.1471-4159.2005.03438.x 10.1016/j.brainresbull.2010.04.006 10.2533/chimia.2018.477 10.1007/s00406-007-0757-8 10.1021/jm100210p 10.1016/j.drudis.2009.05.002 10.1016/j.biopsych.2017.12.019 10.1038/211969a0 10.1038/nsmb.2816 10.1038/nsmb.2894 10.1038/nature12533 10.1038/s41586-019-1135-1 10.1038/s41467-020-14735-w 10.1038/nature06038 10.1038/nature17629 10.1038/ncomms11673 10.1016/j.neuropharm.2011.11.008 10.1016/j.bmcl.2010.09.124 10.1016/S0960-894X(01)00355-9 10.7554/eLife.34317 10.1016/j.sbi.2009.06.002 10.1073/pnas.1903020116 10.1021/acschemneuro.7b00407 10.1016/j.cell.2019.07.028 10.1074/jbc.M609158200 10.1097/ALN.0b013e31823cf233 10.1074/jbc.M704456200 10.1016/j.biopsych.2016.11.014 10.1038/npp.2012.212 10.1016/j.celrep.2017.12.019 10.1074/jbc.270.16.9437 10.1107/S2052252513033939 10.1107/S1399004715017927 10.1107/S0907444909047337 10.1107/S0907444910007493 10.1107/S2059798318002425 10.1107/S2059798319011471 10.1016/j.str.2012.06.009 10.1016/j.str.2008.02.004 10.1021/jm0603365 10.1006/jmbi.1996.0897 10.1093/nar/gkn197 10.1021/jm0011272 10.1093/nar/gkz268 10.1093/nar/gkw408 10.1107/S0907444910045749 10.1073/pnas.1221279110 10.1126/science.1166777 10.1038/nsb0497-269 10.1126/science.1218231
Nature Shahsavar A, Stohler P et. al.

Mar 4th, 2021 - The human glycine transporter 1 (GlyT1) regulates glycine-mediated neuronal excitation and inhibition through the sodium- and chloride-dependent reuptake of glycine1-3. Inhibition of GlyT1 prolongs neurotransmitter signalling, and has long been a ...

see more →

News  2,663 results

'Landmark' Schizophrenia Drug in the Wings? 
https://www.medscape.com/viewarticle/946727

Mar 1st, 2021 - A novel therapy that combines a muscarinic receptor agonist with an anticholinergic agent is associated with a greater reduction in psychosis symptoms compared with placebo, new research shows. In a randomized phase 2 trial comprised of nearly 200...

Inflammatory Immune Findings Likely in Acute Schizophrenia, MDD, Bipolar
https://www.medscape.com/viewarticle/946603

Feb 28th, 2021 - Researchers have come a long way in understanding the link between acute inflammation and treatment-resistant depression, but more work needs to be done, according to Mark Hyman Rapaport, MD. "Inflammation has been a hot topic in the past decade, ...

Clozapine Still Underused in Refractory Schizophrenia
https://www.medscape.com/viewarticle/945771

Feb 11th, 2021 - With the exception of clozapine, the selection of an antipsychotic medication for acute treatment is driven by side effects. That's a key pearl of wisdom that Stephen R. Marder, MD, shared during a discussion of key criteria for choosing an antips...

Placenta's Role in Schizophrenia 'Bigger Than We Imagined'
https://www.medscape.com/viewarticle/945722

Feb 11th, 2021 - Schizophrenia-related genes in the placenta are predictive of the size of a baby's brain at birth and the rate of cognitive development. In a complicated pregnancy, such genes could raise the risk of developing schizophrenia later in life, new res...

Antipsychotic Prescriptions Rising Much Faster than Psychosis Rates
https://www.medscape.com/viewarticle/945257

Feb 3rd, 2021 - While the rates of antipsychotic prescription in England doubled between 2007 and 2014, the odds of having psychotic symptoms rose only slightly over the same period, according to a new study published in  Schizophrenia Research. The researchers u...

see more →

Patient Education  33 results see all →